Applies drugs to fresh tumor tissue in the lab to observe how a patient's cancer actually responds.
Consented intake · your records travel with you · nothing moves without your sign-off
Tony Letai's lab at Dana Farber performs functional testing, applying drugs to fresh tumor tissue and observing the response. Turnaround runs from two days to six weeks, and getting fresh tumor tissue can be a limitation. The goal is to give patients greater confidence, from ex vivo results, that they will respond to a drug or combination before starting it.
The fastest way to know what you'll pay: check your coverage with your plan. Below is what we know about how Tony Letai’s lab at Dana Farber handles billing.
We don't have confirmed insurance details for Tony Letai’s lab at Dana Farber yet. Start a coverage check with your plan, or contact the provider directly.
Answers grounded in Tony's details here. Educational only; your oncologist directs treatment.
Powered by Navis on opencancer.ai
Other providers in similar categories.
Gather distinctive biomarkers that can guide treatment and monitor disease progression
FoundationOne CDx is an FDA-approved comprehensive genomic profiling test that analyzes 324 genes to identify clinically relevant genomic alterations.
Tempus xT is a comprehensive genomic profiling test combining DNA and RNA sequencing to identify actionable mutations.
Matches your tumor's biomarkers to the therapies most likely to work for you — mapping your molecular profile to targeted and approved options.
This page is general information. Upload your records for analysis specific to YOUR diagnosis.